Literature DB >> 20979000

External quality assessment for thrombin generation tests: an exploration.

Cornelis Kluft1, Piet Meijer.   

Abstract

External Quality Control of Diagnostic Assays and Tests (ECAT) surveys on thrombin generation rests (TGTs) have identified that various tests show a more than 30-fold difference in time to peak (TTP). The survey included pooled normal plasmas, microparticle (MP)-depleted plasmas, and factor (F)XII-deficient patient plasma. Between 4 and 11 laboratories participated per test; analyzed were a time (TTP) and quantity variable (AUC). MP depletion of plasma showed a progressive increase in TTP up to 29% with a decreasing tissue factor. The same was found for the AUC with the largest decrease of 38%. It was observed that MP depletion showed large individual differences. The FXII-deficient plasma showed no effect on TTP for rapid tests, but for slow tests it increased from 248 to 331%. The AUC declined gradually the slower the test, reaching a decline of 85%. The effects of FXII deficiency were not mimicked by the addition of corn trypsin inhibitor but were confirmed by inhibiting activated FXI. Interlaboratory variability was between 11% and 57% for all methods, showing differences mainly related to the used normal pooled plasma. The different sensitivities of TGTs to MPs and contact activation predict that they will associate differently with clinical situations, according to which of these aspects are important. Future ECAT surveys should include samples with variation in MPs and contact activation to match with features of the TGT variants. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979000     DOI: 10.1055/s-0030-1265296

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

Review 1.  Introduction to haemostasis from a pharmacodynamic perspective.

Authors:  Cornelis Kluft; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

2.  Characterization of the hypercoagulable state in patients with sickle cell disease.

Authors:  Nirmish Shah; Courtney Thornburg; Marilyn J Telen; Thomas L Ortel
Journal:  Thromb Res       Date:  2012-09-07       Impact factor: 3.944

3.  The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.

Authors:  Marit Hellum; Isabel Franco-Lie; Reidun Øvstebø; Truls Hauge; Carola E Henriksson
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

4.  Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.

Authors:  Jonathan Douxfils; Laure Morimont; Céline Bouvy; Marie de Saint-Hubert; Bérangère Devalet; Célia Devroye; Anne-Sophie Dincq; Jean-Michel Dogné; Maïté Guldenpfennig; Justine Baudar; Anne-Sophie Larock; Sarah Lessire; François Mullier
Journal:  J Thromb Haemost       Date:  2019-05-31       Impact factor: 5.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.